Novel nitric oxide donors are coronary vasodilators that also bind to the papain-like protease of SARS-CoV-2
Description
Several investigational nitric oxide donors were originally created to correct vascular endothelial dysfunction in cardiovascular diseases. These 48 compounds contain an urea-like moiety attached to the well-known NO donors isosorbide 2- and 5
